[HTML][HTML] Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study

M Alavi, MR Mozafari, S Ghaemi, M Ashengroph… - Biomedicines, 2022 - mdpi.com
Severe acute respiratory syndrome (SARS)-CoV-2 from the family Coronaviridae is the
cause of the outbreak of severe pneumonia, known as coronavirus disease 2019 (COVID …

Physicochemical properties, medicinal chemistry, toxicity, and absorption of quercetin and its interaction with spike glycoprotein of SARS-CoV-2: Molecular docking

Q Aljelehawy, OR Mal Allah, G Sourazur - Nano Micro Biosystems, 2022 - nmb-journal.com
Therapeutic targets of coronavirus disease 2019 (COVID-19) may be spike glycoproteins,
main protease (Mpro), and RNA-dependent RNA polymerase (RdRp). The spike …

[HTML][HTML] SARS-CoV-2 spike glycoprotein as inhibitory target for Insilico screening of natural compounds

DA Omoboyowa, A BT, OS Chukwudozie, VN Nweze… - 2021 - europepmc.org
Abstract Coronavirius disease 2019 (Covid-19) pandemic caused by SARS-Cov-2 has
raised global health concern without approved drug for management of this lie threatening …

[HTML][HTML] In silico study unfolds inhibitory potential of epicatechin gallate against SARS-CoV-2 entry and replication within the host cell

P Rajak, A Ganguly - Mechanobiology in Medicine, 2023 - Elsevier
Abstract Coronavirus disease-19 (COVID-19) is the ongoing pandemic affecting millions of
people worldwide. Several vaccine candidates have been designed and developed for the …

[HTML][HTML] Eucalyptus essential oil bioactive molecules from against SARS-CoV-2 spike protein: Insights from computational studies

AD Sharma, I Kaur - 2021 - europepmc.org
Background: SARS-CoV-2 (COVID-19), a positive single stranded RNA virus, member of
corona virus family, is spreading its tentacles across the world due to lack of drugs at …

[PDF][PDF] Natural product emerging as potential SARS spike glycoproteins-ACE2 inhibitors to combat COVID-19 attributed by in-silico investigations

RS Cheke, RR Narkhede… - … Res. Appl. Chem, 2021 - biointerfaceresearch.com
COVID-19 is a pandemic infectious disorder that emerged as a major outbreak for the
community and health care system across the globe. Since the currently available drug …

Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a …

SK Sinha, SK Prasad, MA Islam, SS Gurav… - Journal of …, 2021 - Taylor & Francis
At present, the world is facing a pandemic named as COVID-19, caused by SARS-CoV-2.
Traditional Chinese medicine has recommended the use of liquorice (Glycyrrhiza species) …

[HTML][HTML] In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2

AS Jain, P Sushma, C Dharmashekar… - Saudi Journal of …, 2021 - Elsevier
The novel coronavirus pandemic has spread over in 213 countries as of July 2020.
Approximately 12 million people have been infected so far according to the reports from …

[HTML][HTML] In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2

SK Chidambaram, D Ali, S Alarifi… - Journal of Infection and …, 2020 - Elsevier
Background The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …

[HTML][HTML] Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its …

VK Maurya, S Kumar, AK Prasad, MLB Bhatt… - Virusdisease, 2020 - Springer
The recent outbreak of COVID-19 caused by SARS-CoV-2 brought a great global public
health and economic concern. SARS-CoV-2 is an enveloped RNA virus, from the genus …